Patents by Inventor James C. Costin

James C. Costin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR INHIBITING GAPDH
    Publication number: 20220323452
    Abstract: A method of inhibiting GAPDH with N-methylol transfer agents and/or related compounds.
    Type: Application
    Filed: May 21, 2020
    Publication date: October 13, 2022
    Applicant: Geistlich Pharma AG
    Inventors: Hanns Moehler, James C. Costin, Thomas Mueller
  • OXATHIAZIN_DIOXIDE FOR TREATING, PREVENTING, INHIBITING OR REDUCING CYTOKINE RELEASE
    Publication number: 20220323423
    Abstract: A method of preventing, inhibiting or reducing cytokine release and the incidence of a cytokine release syndrome (CRS) or a cytokine storm in a subject with certain oxathiazin-like compounds and/or related compounds.
    Type: Application
    Filed: May 21, 2020
    Publication date: October 13, 2022
    Applicant: Geistlich Pharma AG
    Inventors: James C. COSTIN, Hanns Moehler, Thomas Mueller
  • OXATHIAZIN COMPOUNDS FOR INHIBITING GAPDH
    Publication number: 20220313702
    Abstract: A method of inhibiting GAPDH with certain oxathiazin-like compounds and/or related compounds.
    Type: Application
    Filed: May 21, 2020
    Publication date: October 6, 2022
    Applicant: Geistlich Pharma AG
    Inventors: Hanns Moehler, James C. Costin, Thomas Mueller
  • Compositions and methods for treating blood
    Patent number: 6608051
    Abstract: A blood collection system and method are disclosed in which taurolidine, a neutralizing agent for pathogens is added to the blood collected in standard blood bags. The taurolidine agent may be prepositioned in the collection bag prior to the collection of blood or alternatively the taurolidine may be added after the collection of blood has been completed.
    Type: Grant
    Filed: March 10, 2000
    Date of Patent: August 19, 2003
    Assignee: MedPointe Healthcare Inc.
    Inventor: James C. Costin
  • Method and compositions for the control or eradication of Helicobacter pylori
    Patent number: 6555534
    Abstract: The use of 4,4-methylenebis (tetrahydro-1,2-4-thiadiazine-1,1 -dioxide) in the eradication and control of the microorganism Helicobacter pylori in humans is disclosed.
    Type: Grant
    Filed: March 10, 1999
    Date of Patent: April 29, 2003
    Assignee: Medpointe Healthcare Inc.
    Inventor: James C. Costin
  • Method and compositions for the eradication and control of methicillin-resistant staphylococcus aureus bacteria and the prevention of the development of antibiotic drug resistance in said bacteria
    Publication number: 20020161003
    Abstract: The use of 4,4-methylenebis (tetrahydro-1,2,4-thiadiazine-1,2-dioxide) in the prevention and control of the development of antibiotic drug resistance in staphylococcus aureus bacteria and in the prevention of bacteria-to-bacteria transfer of genes capable of resisting antibiotics is disclosed.
    Type: Application
    Filed: July 25, 2001
    Publication date: October 31, 2002
    Inventor: James C. Costin
  • Compositions and methods for treating superficial fungal infections
    Patent number: 6436926
    Abstract: Compositions comprising 4,4′-methylenebis(tetrahydro-1,2,4-thiadiazine) 1,1,1′,1′,-tetraoxide and their use in treating dermatologic disorders are disclosed.
    Type: Grant
    Filed: September 4, 2001
    Date of Patent: August 20, 2002
    Assignee: MedPointe, Inc.
    Inventor: James C. Costin
  • Compositions and methods for treating superficial fungal infections
    Publication number: 20020103187
    Abstract: Compositions comprising 4,4′-methylenebis(tetrahydro-1,2,4-thiadiazine) 1,1,1′,1′,-tetraoxide and their use in treating dermatologic disorders are disclosed.
    Type: Application
    Filed: September 4, 2001
    Publication date: August 1, 2002
    Inventor: James C. Costin
  • Compositions and methods for treating infections of the ear
    Patent number: 6350742
    Abstract: The use of 4,4-methylenebis(tetrahydro-1,2,4-thiadiazine-1,2-dioxide) in treating infections of the ear.
    Type: Grant
    Filed: March 10, 1999
    Date of Patent: February 26, 2002
    Assignee: Carter-Wallace, Inc.
    Inventor: James C. Costin
  • Compositions and methods for the management of Crohn's disease
    Patent number: 6251896
    Abstract: The present invention relates to a method of treating a human infected with Crohn's disease comprising enterally administering to the individual in need of such treatment an effective amount of a composition comprising 4,4′-methylenebis-(tetrahydro-1,2,4-thiadiazine)-1,1,1′,1′-tetraoxide, commonly known as taurolidine.
    Type: Grant
    Filed: March 24, 2000
    Date of Patent: June 26, 2001
    Assignee: Carter-Wallace, Inc.
    Inventor: James C. Costin